Imaging dose assessment for IGRT in particle beam therapy
Creators
- 1. Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna (Austria)
- 2. Department of Radiation Oncology, Medical University of Vienna (Austria)
- 3. EBG MedAustron GmbH, Wiener Neustadt (Austria)
- 4. University of Marburg, Department of Radiotherapy and Radiation Oncology (Germany)
- 5. Heidelberg Ion Therapy Center (HIT) (Germany)
- 6. Paul Scherrer Institut, Centre for Proton Therapy, Villigen (Switzerland)
- 7. Ion Beam Applications SA, Proton Therapy Site in Prague (Czech Republic)
- 8. Bioengineering Unit, CNAO Foundation, Pavia (Italy)
- 9. Department of Bioengineering, Politecnico di Milano, Milan (Italy)
Description
Introduction: Image-guided advanced photon and particle beam treatments are promising options for improving lung treatments. Extensive use of imaging increases the overall patient dose. The aim of this study was to determine the imaging dose for different IGRT solutions used in photon and particle beam therapy. Material and methods: Measurements were performed in an Alderson phantom with TLDs. Clinically applied protocols for orthogonal planar kV imaging, stereoscopic imaging, CT scout views, fluoroscopy, CT, 4D-CT and CBCT were investigated at five ion beam centers and one conventional radiotherapy department. The overall imaging dose was determined for a patient undergoing a lung tumor irradiation with institute specific protocols. Results: OAR doses depended on imaging modality and OAR position. Dose values were in the order of 1 mGy for planar and stereoscopic imaging and 10–50 mGy for volumetric imaging, except for one CBCT device leading to lower doses. The highest dose per exam (up to 150 mGy to the skin) was recorded for a 3-min fluoroscopy. Discussion: Modalities like planar kV or stereoscopic imaging result in very low doses (∼1 mGy) to the patient. Imaging a moving target during irradiation, low-dose protocols and protocol optimization can reduce the imaging dose to the patient substantially
Availability note (English)
Available from http://dx.doi.org/10.1016/j.radonc.2013.09.007Additional details
Identifiers
- DOI
- 10.1016/j.radonc.2013.09.007;
- PII
- S0167-8140(13)00465-9;
Publishing Information
- Journal Title
- Radiotherapy and Oncology
- Journal Volume
- 109
- Journal Issue
- 3
- Journal Page Range
- p. 409-413
- ISSN
- 0167-8140
- CODEN
- RAONDT
INIS
- Country of Publication
- Ireland
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 45096108
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CAT SCANNING; FLUOROSCOPY; IMAGES; ION BEAMS; LUNGS; NEOPLASMS; OPTIMIZATION; PARTICLE BEAMS; RADIATION DOSES; RADIOTHERAPY
- Descriptors DEC
- BEAMS; BIOMEDICAL RADIOGRAPHY; BODY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DOSES; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RESPIRATORY SYSTEM; THERAPY; TOMOGRAPHY
Optional Information
- Copyright
- Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.